- 英文名称5,6,7,8-Tetrahydro-1-Naphthol
- 中文名称5,6,7,8-四氢萘-1-醇
- IUPAC名称5,6,7,8-tetrahydronaphthalen-1-ol
- 其它别名5,6,7,8-四氢-1-萘酚,99%; 5,6,7,8-Tetrahydro-1-Naphthol
- CAS编号529-35-1
- MFCD编号:MFCD00001734
- EINECS号:208-461-1
- FDA UNII编号:1R7B5I98HV
- 分子式:C10H12O
- 分子量:148.2
- 产品CID: 1515568
- 产品分类有机原料→分子砌块→芳环类化合物→苯类化合物
欧盟法规
ECHA物质C&L通报REACH预注册上下游产品
CAS号90-15-3 1-萘酚 | CAS号21336-06-1 Cyclohexene, 1,... | CAS号119-64-2 1,2,3,4-四氢萘(THN) | CAS号89228-42-2 4-羟基-5,6,7,8-四氢... | CAS号85531-80-2 2-氧代-5,6,7,8-四氢... | CAS号1125-78-6 5,6,7,8-四氢-2-萘酚 | CAS号108-94-1 环己酮 | CAS号78677-75-5 syn-2,5-Epidiox... | CAS号10465-20-0 1-Naphthalenebu... | CAS号1008-19-1 5-甲氧基-1,2,3,4-四氢萘 | CAS号107203-39-4 2-prop-2-enyl-5... | CAS号107203-35-0 allyl-(5,6,7,8-... | CAS号861094-58-8 allyl-(2-allyl-... | CAS号493-01-6 萘烷 | CAS号493-02-7 反-十氢化萘 | CAS号91-17-8 十氢萘 | CAS号76928-35-3 5,6,7,8-tetrahy... | CAS号628-13-7 吡啶盐酸盐萘酚置于palladium On Activated Charcoal,氢气体系中,用 乙醇 作为反应溶剂,50.0 °C,8.11 Mpa 条件下,反应 8.0H,以95%的收率获得产物四氢萘酚
参考文献:H 4-萘衍生的轴向手性联芳基吡ido胺对α-酮酸的对映选择性仿生氨基转移
标题:H 4-萘衍生的轴向手性联芳基吡ido胺对α-酮酸的对映选择性仿生氨基转移
摘要:不对称仿生转氨反应是合成化学和生物学上重要的手性氨基酸和手性胺的极具吸引力的方法.手性吡ido胺/吡rid醛的开发是反应的关键.已经开发了基于h 4-萘基骨架的新的轴向手性联芳基吡ido胺.吡ido胺在α-酮酸的不对称仿生转氨反应中表现出非常好的对映选择性和高催化活性,可提供多种旋光性非天然氨基酸,产率为61-98%,Ee可达91%.
DOI:10.1016/j.Tetlet.2018.01.089
海关参考信息
- 2902600000-乙苯
2907121100-间甲酚
2908199090-其他酚的卤化衍生物
2908999090-其他酚的硝化衍生物 - 💡 提示:海关信息按照顺序优先匹配,如需确认的海关信息,请参考相关资料。
- 详情请参考:📖 海关编码查询和海关进出口税则
专利信息
专利号:US-10040752-B2
优先权日:2015-08-24
标 题 :Synthesis of levomethadone hydrochloride or dextromethadone hydrochloride and methods for use thereof
发明人:MKRTCHYAN GNEL; YAO QINGWEI
权利人:CODY LABORATORIES INC
摘要:Highly efficient methods for synthesis of levomethadone hydrochloride or dextromethadone hydrochloride are provided starting from D-alanine, or L-alanine, respectively, with retention of configuration. Methods for treating a subject are provided comprising administering a composition comprising an effective amount of levomethadone hydrochloride having not more than 10 ppm dextromethadone.
专利号:US-2004110228-A1
优先权日:2002-04-01
标 题:Combinatorial organic synthesis of unique biologically active compounds
发明人:MCALPINE SHELLI R; TAYLOR RACHEL E; BOLLA MEGAN L; SEGALL ANCA M
摘要:The invention provides a method for making a combinatorial library of cyclic compounds, such as Holliday junction-trapping compounds, comprising the steps of (a) obtaining a plurality of trimers according to the generic structure X 1- X 2- X 3 , wherein X 1 , X 2 and X 3 can be independently any naturally or nonnaturally occurring amino acids or peptidomimetics thereof; (b) optionally coupling a spacer S to the trimer at either end; (c) cyclizing two trimers or trimer-spacer conjugates in a head-to-tail orientation; thereby obtaining a combinatorial library of compounds, wherein the library does not include an unmodifed or naturally occurring Holliday Junction-trapping compounds. The invention additionally provides methods macrocyclic compounds that are synergimycin derivatives.
专利号:US-4758661-A
优先权日:1986-06-24
标题 :Chiral synthesis of (+)-trans-1a,2,3,4a,5,6-hexahydro-9-hydroxy-4-propyl-4H-naphth[1,2-b]-1,4-oxazine
发明人:MELILLO DAVID G; MATHRE DAVID J; LARSEN ROBERT D
权利人:MERCK & CO INC
摘要:(+)-trans-1a,2,3,4a,5,6-Hexahydro-9-hydroxy-4-propyl-4H-naphth[1,2-b]-1,4-oxazine is elaborated by a series of process steps that retain the enantiomeric purity of the starting material, D-aspartic acid. The product is a direct acting dopaminergic agent, useful in the treatment of Parkinson's disease.
专利号:WO-2023122754-A1
优先权日:2021-12-23
标 题 :Processes and intermediates for preparing gb13, gb22 and himgaline
发明人:LANDWEHR ELEANOR; SHENVI RYAN; BAKER MEGHAN; OGUMA TAKUYA
权利人:SCRIPPS RESEARCH INST
摘要:Provided herein are processes for the streamlined synthesis of Galbulimima alkaloids, such as himbadine, isolated from Galbulimima belgraveana and G. baccatta, trees endemic to the rainforests of Northern Australia and Papua New Guinea, as well as analogs thereof, such as GB13, GB16, GB22, and himgaline, and further including intermediates useful in the synthesis of these and related compounds.
专利号:US-2019002394-A1
优先权日:2015-08-24
标 题 :Synthesis of levomethadone hydrochloride or dextromethadone hydrochloride and methods for use thereof
专利号:US-2017057909-A1
优先权日:2015-08-24
标 题 :Synthesis of levomethadone hydrochloride or dextromethadone hydrochloride and methods for use thereof